National Comprehensive Cancer Network (2015). Genetic/familial high-risk assessment: Breast and ovarian. NCCN Clinical Practice Guidelines in Oncology, version 1.2015. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed June 2, 2015.
Kurian AW, et al. (2010). Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 28(2): 222-231. Also available online: http://jco.ascopubs.org/content/28/2/222.full.
Other Works Consulted
Domchek SM, et al. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 304(9): 967-975. Also available online: http://jama.jamanetwork.com/article.aspx?articleid=186510.
National Cancer Institute (2011). Genetics of Breast and Ovarian Cancer (PDQ)-Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/healthprofessional.